Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGIN

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Revealed
India's Third Giant Leap

This Could be One of the Biggest Opportunities for Investors




Important: We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
By submitting your email address, you also sign up for Profit Hunter, a daily newsletter from Equitymaster
covering exciting investing ideas and opportunities in India.

AD

Mid, smallcaps in favour
Fri, 19 Oct 11:30 am

The Indian equity markets continued to trade below the dotted line during the past two hours. While stocks from the consumer durables, healthcare and information technology spaces are leading the pack of gainers, those from the oil & gas, power and metals spaces are leading the pack of losers.

The Sensex today is trading lower by about 60 points (down 0.3%), while the NSE-Nifty is trading lower by about 20 points (down 0.3%). Stocks from the midcap and smallcap spaces are however trading firm with the BSE Mid Cap and BSE Small Cap indices up by about 0.2% and 0.4% respectively. The rupee is trading at 53.7 to the US dollar.

Stocks of healthcare companies are trading firm with Biocon, Lupin, and Sanofi India leading the gains. Lupin recently received the approval from the US Food and Drugs Administration (USFDA) to market oral contraceptive tablets 'Kurvelo' in the US market. Kurvelo tablets are the generic equivalent of Teva's Nordette tablets having a market size of US$ 59mn, which are used for prevention of pregnancy in women. It is believed that the oral contraceptive market in the US is valued at over US$ 5 bn (Rs 268 bn approximately) and is believed to be growing at the rate of 8% annually. Further, Lupin has nearly 30 abbreviated new drug applications filings for the oral contraceptive market, which is the largest pipeline for the market in the US.

Media stocks are trading mixed with gains led by TV Today Network and Zee News Siti Cable and Deccan Chronicle are the top losers. Print media company DB Corp declared results for the second quarter of FY13 (2QFY13). The company reported a sales growth of 7.8% YoY during the quarter and of 7.4% YoY during the half year ended September 2012. Operating expenditure was up by 3.9% YoY during the quarter resulting in operating profits increasing by 23.8% YoY. For the half year period, operating profits fell by 3.4% YoY. The company was able to lower its interest burden by 7.3% YoY for the quarter. The same expenses were down by 17% for the half year. Despite a higher tax outgo which grew by 26.9% YoY, DB Corp reported a net profit growth of 20.6% YoY. Net profits expanded by 1.5%.

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

View all commentaries | Archives

Read the latest Market Commentary


Equitymaster requests your view! Post a comment on "Mid, smallcaps in favour". Click here!

  
ABOUT EQUITYMASTER

Since 1996, Equitymaster has been the source for honest and credible opinions on investing in India. With solid research and in-depth analysis Equitymaster is dedicated towards making its readers- smarter, more confident and richer every day. Here's why hundreds of thousands of readers spread across more than 70 countries Trust Equitymaster.

PREMIUM PRODUCTS
QUICK LINKS
POPULAR TOPICS
TRENDING TOPICS
FREE NEWSLETTERS
EQUITYMASTER SUPPORTS
  • HelpYourNGO
  • You Tube
  • Linkedin
  • Twitter
  • Telegram
  • Google Play

Copyright © Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited).

Whitelist | Refer | Terms | Privacy | Contact | About | Sitemap

Phone +91-9136015013

Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited) (Research Analyst)
SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.

103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Email: info@equitymaster.com. Website: www.equitymaster.com.
CIN:U74999MH2007PTC175407

Name of the Compliance & Grievance Officer: Ms Sonal Ramachandran
Telephone: +91-22-61434003 | Email: compliance@equitymaster.com

LEGAL DISCLAIMER:
Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

All rights reserved. Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.

Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited) (Research Analyst) bearing Registration No. INH000000537 (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA, Canada or the European Union countries, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.